LabHealth
NAT10’s helicase domain fuels tumor growth in lab and animal models
Northwestern researchers tested more than 1,900 NAT10 variants in one proliferation assay.
Written by AI1 source1 min
Loading…
Diagnostics, prosthetics, vaccines, genomics: the medicine that adds years to a life.
Northwestern researchers tested more than 1,900 NAT10 variants in one proliferation assay.
L-32 targets PTPN22, a protein that restrains immune activity.
The combination pushed tumor-cell DNA damage beyond repair, triggering programmed cell death.
WashU researchers found lymph node-like structures in the skull marrow of mice and evidence of similar cells in humans.
The work remains preclinical, using human cells, organoids and laboratory models.